A prospective open‐label trial of a CBD/THC cannabis oil in dravet syndrome

A prospective open‐label trial of a CBD/THC cannabis oil in dravet syndrome

Abstract Introduction Both Δ9 Tetrahydrocannabidiol (THC) and cannabidiol (CBD) components of cannabis, have been shown to have anticonvulsant effects. Cannabis oils are used to treat seizures in drug‐resistant epilepsy (DRE). Recent trials provide data on dosing, side effects, and efficacy of CBD,...

Full description

Bibliographic Details
Main Authors:	Bláthnaid McCoy, Laura Wang, Maria Zak, Sameer Al‐Mehmadi, Nadia Kabir, Kenda Alhadid, Kyla McDonald, Grace Zhang, Rohit Sharma, Robyn Whitney, Katia Sinopoli, O. Carter Snead III
Format:	Article
Language:	English
Published:	Wiley 2018-09-01
Series:	Annals of Clinical and Translational Neurology
Online Access:	https://doi.org/10.1002/acn3.621

Similar Items

Medical Marijuana, CBD and THC
by: Calhoun, McKenzie L.
Published: (2019)

<i>Cannabis sativa</i>: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
by: Jackson M. J. Oultram, et al.
Published: (2021-02-01)

CBD, a precursor of THC in e-cigarettes
by: Zsuzsanna Czégény, et al.
Published: (2021-04-01)

Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats
by: Marina Gabaglio, et al.
Published: (2021-08-01)

The Impact of THC and CBD in Schizophrenia: A Systematic Review
by: Saeed Ahmed, et al.
Published: (2021-07-01)

Effects of Ethanol on the Supercritical Carbon Dioxide Extraction of Cannabinoids from Near Equimolar (THC and CBD Balanced) Cannabis Flower
by: Sadia Qamar, et al.
Published: (2021-09-01)

Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD Cannabis Herbal Extract in Dogs
by: Alan Chicoine, et al.
Published: (2020-09-01)

A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC
by: Seok Hee Kim, et al.
Published: (2019-12-01)

Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer
by: Farjana Afrin, et al.
Published: (2020-04-01)

A classification of endangered high-THC cannabis (Cannabis sativa subsp. indica) domesticates and their wild relatives
by: John M. McPartland, et al.
Published: (2020-04-01)

Vape shop owners’/managers’ attitudes about CBD, THC, and marijuana legal markets
by: Carla J. Berg, et al.
Published: (2020-12-01)

Biomechanical Effects of Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD), the Major Constituents of Cannabis, in a Sprague Dawley Rat Achilles Tendon Surgical Repair Model
by: Chris M. Stauch, et al.
Published: (2020-10-01)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
by: Patricia Golombek, et al.
Published: (2020-06-01)

A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain
by: Überall MA
Published: (2020-02-01)

Acute effects of naturalistic THC vs. CBD use on recognition memory: a preliminary study
by: Tim Curran, et al.
Published: (2020-09-01)

The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).
by: Alessandro Enrico Grimaldi, et al.
Published: (2019-01-01)

Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
by: Uwe K. Zettl, et al.
Published: (2016-01-01)

Do Cannabis Users Reduce Their THC Dosages When Using More Potent Cannabis Products? A Review
by: Janni Leung, et al.
Published: (2021-02-01)

Spiders, ladybugs and bees: A case of unusual sensations in a child with cingulate epilepsy
by: Robyn Whitney, et al.
Published: (2017-01-01)

Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83
by: Daniela Cerretani, et al.
Published: (2020-08-01)

Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)
by: Thomas Meyer, et al.
Published: (2019-09-01)

Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination? [version 2; peer review: 2 approved]
by: Dirk W. Lachenmeier, et al.
Published: (2020-02-01)

The frequency distribution of reported THC concentrations of legal cannabis flower products increases discontinuously around the 20% THC threshold in Nevada and Washington state
by: Michael J. Zoorob
Published: (2021-03-01)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
by: Lourdes Poyatos, et al.
Published: (2020-06-01)

Dravet syndrome
by: Incorpora Gemma
Published: (2009-09-01)

Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis
by: Fabricio A. Pamplona, et al.
Published: (2018-09-01)

Changes on metabolic parameters induced by acute cannabinoid administration (CBD, THC) in a rat experimental model of nutritional vitamin A deficiency
by: Loubna El Amrani, et al.
Published: (2013-06-01)

Variability of Multiple Sclerosis Spasticity Symptoms in Response to THC:CBD Oromucosal Spray: Tracking Cases through Clinical Scales and Video Recordings
by: Peter Flachenecker, et al.
Published: (2018-07-01)

In vitro tissue culture and genetic analysis of two high-CBD medical cannabis (Cannabis sativa L.) breeding lines
by: Mestinšek-Mubi Špela, et al.
Published: (2020-01-01)

Corrigendum: Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis
by: Fabricio A. Pamplona, et al.
Published: (2019-01-01)

Study of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extraction FROM dried oral fluid spots (DOFS) and LC–MS/MS detection
by: Roberta Gorziza, et al.
Published: (2021-07-01)

Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination? [version 4; peer review: 2 approved, 1 approved with reservations]
by: Dirk W. Lachenmeier, et al.
Published: (2021-07-01)

Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination? [version 3; peer review: 2 approved, 1 approved with reservations]
by: Dirk W. Lachenmeier, et al.
Published: (2020-08-01)

Phenotypes of Dravet Syndrome
by: Rebecca Garcia-Sosa, et al.
Published: (2016-08-01)

Vaccinations and Dravet Syndrome
by: Christian M. Korff
Published: (2015-12-01)

RhEology of thc TEctonosphere in thc Short time rangc
by: A. E. SCHEIDEGGER
Published: (1971-06-01)

Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination.
by: Katja Linher-Melville, et al.
Published: (2020-01-01)

An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland, who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray
by: Etges T, et al.
Published: (2016-11-01)

Efficacy of Δ9 -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice
by: Prakash Nidadavolu, et al.
Published: (2021-08-01)

Augmenting Nutrient Acquisition Ranges of Greenhouse Grown CBD (Cannabidiol) Hemp (<i>Cannabis sativa</i>) Cultivars
by: Jennifer Kalinowski, et al.
Published: (2020-12-01)